text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2022년 03월 31일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\nHPI, INC.\n비상장\n2007.09.14\n해외임상시험\n187\n200,000\n100.0\n75\n-\n-\n-\n200,000\n100.0\n75\n279\n-64\nImmuno MET\n비상장\n2015.08.24\n투자\n2,173\n1,194,503\n15.60\n13,339\n-\n-\n-\n1,194,503\n15.60\n13,339\n4,750\n-8,605\nImmunovant Sciences Ltd.\n상장\n2019.01.11\n투자\n5,609\n939,395\n0.82\n9,488\n-\n-\n-3,221\n939,395\n0.82\n6,267\n644\n-125\nNurron Pharmaceuticals, Inc\n비상장\n2021.07.19\n투자\n571\n58,343\n2.37\n571\n-\n-\n-\n58,343\n2.37\n571\n3,469\n-1,695\n합 계\n2,392,241\n-\n23,473\n-\n-\n-3,221\n2,392,241\n-\n20,252\n9,141\n-10,490\n']"
